Intelligent Approach to Traditional Chinese Medicine for Insomnia
TCM
Intelligent Complementary Diagnosis and Treatment of Traditional Chinese Medicine for Primary Insomnia
1 other identifier
interventional
120
0 countries
N/A
Brief Summary
Insomnia is a very common health issue, affecting over 40% of the population in Chinese-speaking regions. The impact of insomnia on society, economy, mental health, and physical health is significant, with previous research indicating that insomnia is associated with an increased risk of high blood pressure, heart disease, anxiety, and depression, which can ultimately lead to a decline in quality of life. Treatment for insomnia includes non-pharmacological and pharmacological interventions, with clinical practice often utilizing sedative medications for sleep, but with side effects such as dependency, tolerance, daytime drowsiness, and withdrawal symptoms, which make it challenging for patients to find suitable medical treatment. Traditional Chinese Medicine (TCM) approaches insomnia by first conducting a thorough assessment based on individualized patterns (differentiation of body constitution) and evaluating insomnia-related symptoms, followed by an examination of tongue and pulse to determine the correct treatment plan, which may involve acupuncture, herbal medicine or a combination of both (integrative treatment). Due to the complex nature of insomnia, a definitive diagnosis requires neuroimaging and other measures during sleep studies to assess brain wave activity, if possible, to understand the cognitive impact.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 10, 2025
CompletedStudy Start
First participant enrolled
May 28, 2025
CompletedFirst Posted
Study publicly available on registry
May 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 19, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMay 30, 2025
May 1, 2025
7 months
February 10, 2025
May 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Questionnaire evaluation
Pittsburgh Sleep Quality Index, PSQI)
up to 4 weeks"
Study Arms (1)
Randomized controlled cross-over experimental design
EXPERIMENTALStruggling to fall asleep or stay asleep, experiencing frequent awakenings, or finding it challenging to return to sleep after waking up. Waking up early in the morning and being unable to go back to sleep. Sleep disturbances leading to significant distress or impairment in various aspects of life such as social, occupational, or academic functioning. Experiencing difficulty sleeping on at least three nights a week for a period of at least three months. No use of hypnotic or stable use of hypnotic and no medication adjustment in the past month
Interventions
Incorporate the following regimen into your daily routine for optimal health benefits: Chinese Medicine: Take a combination of Modified Xiaoyao Powder (2g), Tianwang Buxin Dan (1.5g), Wendan Decoction (0.5g), Night Jiaoteng (0.5g), and Fushen (0.5g) twice a day for a duration of 1 month. This regimen comes from Keda GMP Pharmaceutical Factory. Auricular Point Stimulation: Apply small 0.2cm ear magnetic beads on the Shenmen, heart, and brainstem points on both sides of the ear. Consistency is key to achieving positive results, so make sure to follow this routine diligently. Two treatment methods are carried out simultaneously
Eligibility Criteria
You may qualify if:
- Major mental illnesses include schizophrenia, bipolar disorder, major depression, dementia, apnea, restless legs syndrome, alcohol and substance abuse, organic psychosis and those with major physiological illnesses that affect sleep.
You may not qualify if:
- As per the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) published by the American Psychiatric Association, insomnia is characterized.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 10, 2025
First Posted
May 30, 2025
Study Start
May 28, 2025
Primary Completion
December 19, 2025
Study Completion
December 31, 2025
Last Updated
May 30, 2025
Record last verified: 2025-05